Copyright
©The Author(s) 2021.
World J Clin Cases. Jul 16, 2021; 9(20): 5611-5620
Published online Jul 16, 2021. doi: 10.12998/wjcc.v9.i20.5611
Published online Jul 16, 2021. doi: 10.12998/wjcc.v9.i20.5611
Ref. | Year | Age | Gender | Dose of clozapine | Blood concentration of clozapine | Blood concentration of norclozapine | Type of seizure | EEG | Antiepileptic drugs | Further use of clozapine | Other psychiatric drugs |
Usiskin et al[47] | 2000 | 15 | M | 400 mg/d | - | - | Myoclonus and GTCS | Bihemispheric epileptiform activity | Gabapentin 2100 mg/dClonazepam 2 mg/d | 300 mg/d | Olanzapine 25 mg/d |
Navarro et al[48] | 2001 | 23 | F | 200 mg/d | - | - | GTCS | Bihemispheric epileptiform activity | Topiramate 200 mg/d | 200 mg/d | - |
Haberfellner[31] | 2002 | 29 | F | 150 mg/d | - | - | Myoclonus and GTCS | Paroxysmal generalized spikes | - | 100 mg/d | Haloperidol 10 mg/d |
Duggal et al[49] | 2002 | 28 | M | 300 mg/d | - | - | Stuttering | - | - | - | - |
425 mg/d | - | - | GTCS | Generalized nonparoxysmal slowing and a photic convulsive response | Valproate 800 mg/d | 300 mg/d | - | ||||
Foster et al[50] | 2005 | 32 | F | 125 mg/d | - | - | TCS | - | - | - | - |
237.5 mg/d | - | - | TCS | - | Valproate 500 mg/d | 450 mg/d | Citalopram 20 mg/d | ||||
Begum et al[51] | 2005 | - | - | 300 mg/d | - | - | Myoclonus and stuttering | - | Valproate 400 mg/d | 300 mg/d | - |
Muzyk et al[52] | 2010 | 20 | M | 600 mg/d | - | - | Myoclonus and GTCS | - | Lamotrigine 200 mg/d | 550 mg/d | Lithium 900 mg/d |
Praharaj et al[32] | 2010 | 38 | M | 250 mg/d | - | - | Myoclonus | Bilateral frontal theta waves and sharp–slow wave | Clonazepam 1000 mg/d | 250 mg/d | - |
Horga et al[33] | 2010 | 15 | M | 350 mg/d | - | - | Speech dysfluency and myoclonus | - | - | 300 mg/d | Clomipramine 225 mg/d |
300 mg/d | - | - | GTCS | Generalized andMultifocal paroxysmal epileptiform discharges | Sodium valproate 500 mg/d | 300 mg/d | Clomipramine 225 mg/d | ||||
Leung et al[53] | 2014 | 52 | F | 450 mg/d | 1400 ng/mL (36 h after the last dose) | 606 ng/mL (36 h after the last dose) | Myoclonus | - | - | 225.5 mg/d | - |
Park et al[34] | 2014 | 26 | F | 450 mg/d | - | - | GTCS | - | - | 300 mg/d | - |
300 mg/d | - | - | GTCS | No epileptiform discharge | Valproate 250 mg | Drug withdrawal | ECT, risperidone 6 mg/d, escitalopram 15 mg/d | ||||
Kikuchi et al[35] | 2014 | 19-48 | F (n = 12) | 275-600 mg/d | - | - | TCS and myoclonic (n =1) TCS (n = 1) Myoclonic (n = 4) | Spike and slow wave | Lamotrigine 150-300 mg/d (n = 2) Valproate 400-800 mg/d (n = 3) | 200-550 mg/d | - |
Grover et al[6] | 2015 | 24-63 | F (n = 3) M (n = 9) | 150-600 mg/d | - | - | GTCS (n = 12) | - | Lamotrigine (n = 1) Valproate 1000 mg/d (n = 3) | 150-600 mg/d | Haloperidol (n = 1) Sertraline 75 mg/d (n = 1) |
Osborne et al[41] | 2015 | 20 | M | 400 mg/d | 140 ng/mL | 130 ng/mL | Myoclonus | - | - | - | - |
400 mg/d | 180 ng/mL | 150 ng/mL | GTCS | - | Valproate 1000 mg/d | 475 mg/d | - | ||||
Bolu et al[29] | 2017 | 29 | M | 200 mg/d | - | - | TCS | Bilateral diffuse epileptic activity | Valproate 1000 mg/d | 100 mg/d | - |
Rachamallu et al[54] | 2017 | 16 | M | 350 mg/d | - | - | Orofacial dyskinesia with perioral twitching | - | - | - | - |
400 mg/d | - | - | Stuttering | Several episodes of generalized spike | Valproate 1000 mg/d | 450 mg/d | - | ||||
Borah et al[30] | 2019 | 42 | F | 300 mg/d | - | - | Twitching and urinary incontinence | - | - | 250 mg/d | Haloperidol 10 mg/d |
Chochol et al[55] | 2019 | 57 | M | 600 mg/d | 866 ng/mL | 301 ng/mL | Myoclonus and stuttering | Bilateral sharp waves and slow wave complexes | - | 300 mg/d | Risperidone 1.5 mg/d, Risperidone 37.5 mg every 2 wk |
- Citation: Le DS, Su H, Liao ZL, Yu EY. Low-dose clozapine-related seizure: A case report and literature review . World J Clin Cases 2021; 9(20): 5611-5620
- URL: https://www.wjgnet.com/2307-8960/full/v9/i20/5611.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i20.5611